-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AJbvoS9Y2wz0zCenc1hlfV8MNCtlKBFx7WKMDF/7Es/sn4wr0d3vqdAH4U9jvjYZ YflK8Qi2J/XyvXGh3v8LaA== 0001047469-99-001089.txt : 19990114 0001047469-99-001089.hdr.sgml : 19990114 ACCESSION NUMBER: 0001047469-99-001089 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990113 GROUP MEMBERS: BIOTECHNOLOGY VALUE FUND L P ET AL GROUP MEMBERS: BVF INC. GROUP MEMBERS: BVF PARTNERS L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TRIMERIS INC CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-52299 FILM NUMBER: 99505872 BUSINESS ADDRESS: STREET 1: 4727 UNIVERSITY DR STE 100 CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 9194196050 MAIL ADDRESS: STREET 1: 4727 UNIVERSITY DRIVE STE 100 CITY: DURHAM STATE: NC ZIP: 27707 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND L P ET AL CENTRAL INDEX KEY: 0000918923 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 363924731 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: 39TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-288-2395 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: 39TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 SC 13D/A 1 SCHED 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------- SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) (AMENDMENT NO. 1)(1) TRIMERIS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 896263 10 0 (CUSIP Number) Marc Schneidman BVF Partners L.P. 333 West Wacker Drive, Suite 1600 Chicago, Illinois 60606 (312) 263-7777 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 17, 1998 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission. SEE Rule 13d-1(a) for other parties to whom copies are to be sent. (Continued on following pages) (Page of 7 Pages) - -------------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, SEE the NOTES). - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 2 of 7 Pages - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BIOTECHNOLOGY VALUE FUND, L.P. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- NUMBER OF -------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 258,500 OWNED BY -------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- -------------------------------------------------- 10 SHARED DISPOSITIVE POWER 258,500 - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 258,500 - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - ------------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 3 of 7 Pages - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BVF PARTNERS L.P. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- NUMBER OF --------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 523,000 REPORTING --------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER -0- --------------------------------------------------- 10 SHARED DISPOSITIVE POWER 523,000 - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 523,000 - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.9% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - ------------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 4 of 7 Pages - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BVF INC. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC, OO - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- NUMBER OF --------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 523,000 REPORTING --------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER -0- --------------------------------------------------- 10 SHARED DISPOSITIVE POWER 523,000 - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 523,000 - ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.9% - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IA, CO - ------------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 5 of 7 Pages - ------------------------------------------------------------------------------- Amendment No. 1 (the "Amendment") to the Statement on Schedule 13D, dated September 8, 1998 (as so amended, the "Statement"), filed with the Securities and Exchange Commission on behalf of Biotechnology Value Fund, L.P., a Delaware limited partnership ("BVF"), BVF Partners L.P., a Delaware limited partnership ("Partners"), and BVF Inc., a Delaware corporation ("BVF Inc." and, together with BVF and Partners, the "Reporting Persons") with respect to the Common Stock (the "Stock"), of Trimeris Inc., a Delaware corporation ("Trimeris"). Item 3 is hereby amended to read in its entirety as follows: ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Since September 17, 1998, Partners, in its capacity as general partner of BVF, has purchased on behalf of such limited partnership an aggregate number of 31,500 shares of the Stock for an aggregate consideration of $139,185.20, utilizing funds provided by BVF from its working capital pursuant to the terms of its limited partnership agreement with Partners, and has sold on behalf of such limited partnership an aggregate number of 29,000 shares of the Stock for an aggregate consideration of $278,111.41. In addition, Partners, in its capacity as investment manager with respect to certain managed accounts, has purchased on behalf of such managed accounts an aggregate number of 21,000 shares of the Stock for an aggregate consideration of $89,417.60, utilizing funds under management by Partners pursuant to investment management agreements between Partners and such managed accounts, and has sold on behalf of such managed accounts an aggregate number of 53,500 shares of the Stock for an aggregate consideration of $506,447.62. Item 5 is hereby amended to read in its entirety as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) BVF beneficially owns 258,500 shares of the Stock, Partners beneficially owns 523,000 shares of the Stock, and BVF Inc. beneficially owns 523,000 shares of the Stock, approximately 2.4%, 4.9% and 4.9%, respectively, of the aggregate number of shares outstanding as of November 12, 1998 (as reported in Trimeris' most recent quarterly statement on Form 10-Q). (b) BVF shares voting and dispositive power over the 258,500 shares of the Stock it beneficially owns with Partners. Partners and BVF Inc. share voting and dispositive power over the 523,000 shares of the Stock they beneficially own with, in addition to BVF, the managed accounts on whose behalf Partners, as investment manager, purchased such shares. The managed accounts on whose behalf Partners owns shares of the Stock are Investment 10 L.L.C., an Illinois limited liability company ("ILL10"), Palamundo, L.D.C., a limited duration company organized under the laws of the Cayman Islands ("Palamundo"), ZPG - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 6 of 7 Pages - ------------------------------------------------------------------------------- Securities, L.L.C., a New York limited liability company ("ZPG") and Biotechnology Value Fund, Ltd., a Cayman Islands Corporation ("BVF Ltd."). ILL10, Palamundo, ZPG and BVF Ltd. are collectively referred to herein as the "Accounts." The Accounts specialize in holding biotechnology stocks for investment purposes and the business address of each is BVF Partners L.P., 333 West Wacker Drive, Suite 1600, Chicago, Illinois 60606. (c) Exhibit B attached hereto contains information as to all transactions in the Stock by the Reporting Persons during the last 60 days. All such transactions were made for cash in open market, over-the-counter transactions. No other transactions in the Stock have been effected by the Reporting Persons during the last 60 days. (d) The Accounts are entitled to receive dividends and any sale proceeds with respect to the Stock in proportion to their respective ownership interests therein. (e) The Reporting Persons ceased to be the beneficial owners of more than five percent of the Stock on December 17, 1998. Item 7 is hereby amended to read in its entirety as follows: ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit A - Agreement Regarding Joint Filing Exhibit B - Transactions in the Stock by the Reporting Persons during the last 60 days. - ------------------------------------------------------------------------------- CUSIP NO. 896263 10 0 13D Page 7 of 7 Pages - ------------------------------------------------------------------------------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 11, 1999 BIOTECHNOLOGY VALUE FUND, L.P. By: BVF Partners L.P., its general partner By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President BVF PARTNERS L.P. By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President BVF INC. By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President EXHIBIT A AGREEMENT REGARDING JOINT FILING The undersigned, Biotechnology Value Fund, L.P., a Delaware limited partnership, and BVF Partners L.P., a Delaware limited partnership, and BVF Inc., a Delaware corporation, hereby agree and acknowledge that the Amendment containing the information required by Schedule 13D, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any further amendments or supplements thereto shall also be filed on behalf of each of them. Dated: January 11, 1999 BIOTECHNOLOGY VALUE FUND, L.P. By: BVF Partners L.P., its general partner By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President BVF PARTNERS L.P. By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President BVF INC. By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President EXHIBIT B TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS DURING THE PAST SIXTY DAYS
- ---------------------------------------------------------------------------------------------------------------------------------- For the Price per Trade Date By Account of Quantity Share Type of Trade Broker - ---------------------------------------------------------------------------------------------------------------------------------- 09/28/98 BVF Partners 3,000 $5.5417 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 09/30/98 BVF Partners 6,000 $5.1875 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 09/30/98 ILL10 Partners 1,000 $5.1875 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 09/30/98 PAL Partners 1,000 $5.1875 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 10/07/98 BVF Partners 6,500 $4.2500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/07/98 ILL10 Partners 2,000 $4.2500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/07/98 PAL Partners 2,000 $4.2500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/07/98 ZPG Partners 1,000 $4.2500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/07/98 BVF Ltd. Partners 5,000 $4.2500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/08/98 BVF Partners 5,500 $4.1250 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/08/98 BVF Ltd. Partners 5,500 $4.1250 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/09/98 BVF Partners 1,000 $3.9375 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 10/09/98 BVF Partners 2,500 $4.0000 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/12/98 BVF Partners 3,500 $3.9286 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/12/98 BVF Ltd. Partners 3,500 $3.9286 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/13/98 BVF Partners 2,500 $3.7500 Purchase MONT - ---------------------------------------------------------------------------------------------------------------------------------- 10/14/89 BVF Partners 1,000 $3.7500 Purchase INET - ---------------------------------------------------------------------------------------------------------------------------------- 11/03/98 BVF Partners (19,000) $9.6328 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 11/03/98 BVF Ltd. Partners (18,000) $9.6328 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 11/03/98 BVF Partners (3,000) $10.0000 Sale INET - ---------------------------------------------------------------------------------------------------------------------------------- 11/03/98 PAL Partners (3,000) $9.6328 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/14/98 ILL10 Partners (2,000) $9.5000 Sale INET - ---------------------------------------------------------------------------------------------------------------------------------- 12/15/98 ILL10 Partners (10,000) $9.3839 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/15/98 BVF Ltd. Partners (7,500) $9.3839 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/17/98 BVF Partners (7,000) $9.3125 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/17/98 PAL Partners (3,000) $9.3125 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/17/98 ZPG Partners (2,000) $9.3125 Sale MONT - ---------------------------------------------------------------------------------------------------------------------------------- 12/17/98 BVF Ltd. Partners (8,000) $9.3125 Sale MONT - ----------------------------------------------------------------------------------------------------------------------------------
INET = Instinet MONT = Montgomery Securities -----END PRIVACY-ENHANCED MESSAGE-----